ESR1 and breast carcinoma: Breast cancer, as a heterogeneous malignancy, should not be considered a single disease and can be classified into different major subtypes based on Estrogen receptor (ER) status: Estrogen‐receptor‐positive (ER+) and Estrogen‐receptor‐negative (ER−), which ER+ accounts for about 70% of breast cancer.11